NO20023803L - Anvendelse av mirtazapin for behandling av sövnforstyrrelser - Google Patents

Anvendelse av mirtazapin for behandling av sövnforstyrrelser

Info

Publication number
NO20023803L
NO20023803L NO20023803A NO20023803A NO20023803L NO 20023803 L NO20023803 L NO 20023803L NO 20023803 A NO20023803 A NO 20023803A NO 20023803 A NO20023803 A NO 20023803A NO 20023803 L NO20023803 L NO 20023803L
Authority
NO
Norway
Prior art keywords
mirtazapine
treatment
sleep disorders
sleep
disorders
Prior art date
Application number
NO20023803A
Other languages
English (en)
Other versions
NO328007B1 (no
NO20023803D0 (no
Inventor
Gerardus Stephanus Franc Ruigt
Frans Van Den Berg
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20023803D0 publication Critical patent/NO20023803D0/no
Publication of NO20023803L publication Critical patent/NO20023803L/no
Publication of NO328007B1 publication Critical patent/NO328007B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20023803A 2000-02-11 2002-08-09 Anvendelse av mirtazapin for fremstilling av medikament for behandling av sovnforstyrrelser NO328007B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200499 2000-02-11
PCT/EP2001/001221 WO2001058453A1 (en) 2000-02-11 2001-02-06 The use of mirtazapine for the treatment of sleep disorders

Publications (3)

Publication Number Publication Date
NO20023803D0 NO20023803D0 (no) 2002-08-09
NO20023803L true NO20023803L (no) 2002-10-09
NO328007B1 NO328007B1 (no) 2009-11-09

Family

ID=8171013

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023803A NO328007B1 (no) 2000-02-11 2002-08-09 Anvendelse av mirtazapin for fremstilling av medikament for behandling av sovnforstyrrelser

Country Status (25)

Country Link
US (1) US6933293B2 (no)
EP (4) EP1658850A1 (no)
JP (1) JP5039994B2 (no)
KR (1) KR20020069371A (no)
CN (2) CN1395487A (no)
AR (1) AR027394A1 (no)
AT (1) ATE317261T1 (no)
AU (1) AU780439B2 (no)
BR (1) BR0108261A (no)
CA (1) CA2396209C (no)
CO (1) CO5271706A1 (no)
CZ (1) CZ302368B6 (no)
DE (1) DE60117122T2 (no)
DK (1) DK1257278T3 (no)
ES (1) ES2258071T3 (no)
HK (1) HK1049122B (no)
HU (1) HUP0204391A3 (no)
IL (2) IL150290A0 (no)
NO (1) NO328007B1 (no)
PE (1) PE20011080A1 (no)
PL (1) PL206073B1 (no)
RU (1) RU2270680C2 (no)
SK (1) SK287396B6 (no)
WO (1) WO2001058453A1 (no)
ZA (1) ZA200205238B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152055A1 (en) * 2003-01-30 2004-08-05 Gliessner Michael J.G. Video based language learning system
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
EP1689371A2 (en) * 2003-11-25 2006-08-16 Aurobindo Pharma Limited Pharmaceutical compositions of mirtazapine
GB0417558D0 (en) * 2004-08-06 2004-09-08 Merck Sharp & Dohme Novel combination therapy
KR100870381B1 (ko) * 2004-10-14 2008-11-25 다이킨 고교 가부시키가이샤 분위기개변방법, 그리고 이에 이용되는 분무제 및 분무장치
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
JP2007284363A (ja) * 2006-04-13 2007-11-01 Daikin Ind Ltd 噴霧剤
CN101679431B (zh) 2007-04-11 2013-08-14 Msd欧斯股份有限公司 制备四环苯并氮杂卓的对映异构体的方法
DK3261645T3 (da) 2015-02-27 2021-06-07 Dechra Ltd Stimulering af appetit, håndtering af vægttab og behandling af anoreksi hos hunde og katte
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
CN1154495C (zh) * 1997-11-14 2004-06-23 阿克佐诺贝尔公司 米氮平用于治疗睡眠性呼吸暂停的用途

Also Published As

Publication number Publication date
DE60117122T2 (de) 2006-07-27
SK11442002A3 (sk) 2003-02-04
EP1656937A1 (en) 2006-05-17
DE60117122D1 (de) 2006-04-20
CZ302368B6 (cs) 2011-04-13
SK287396B6 (sk) 2010-08-09
WO2001058453A1 (en) 2001-08-16
CN101229170A (zh) 2008-07-30
HUP0204391A3 (en) 2005-03-29
PL356721A1 (en) 2004-06-28
ZA200205238B (en) 2003-09-29
ATE317261T1 (de) 2006-02-15
PE20011080A1 (es) 2001-10-18
BR0108261A (pt) 2003-03-05
CZ20022330A3 (cs) 2002-11-13
HK1049122B (zh) 2006-04-21
HUP0204391A2 (en) 2003-05-28
IL150290A (en) 2010-12-30
RU2002124141A (ru) 2004-03-10
PL206073B1 (pl) 2010-06-30
AU3024701A (en) 2001-08-20
JP5039994B2 (ja) 2012-10-03
EP1257278A1 (en) 2002-11-20
CA2396209C (en) 2009-09-01
AR027394A1 (es) 2003-03-26
US20030022888A1 (en) 2003-01-30
US6933293B2 (en) 2005-08-23
CN1395487A (zh) 2003-02-05
RU2270680C2 (ru) 2006-02-27
HK1049122A1 (en) 2003-05-02
NO328007B1 (no) 2009-11-09
CO5271706A1 (es) 2003-04-30
IL150290A0 (en) 2002-12-01
ES2258071T3 (es) 2006-08-16
DK1257278T3 (da) 2006-06-12
EP2283840A1 (en) 2011-02-16
KR20020069371A (ko) 2002-08-30
NO20023803D0 (no) 2002-08-09
JP2003522147A (ja) 2003-07-22
EP1658850A1 (en) 2006-05-24
AU780439B2 (en) 2005-03-24
CA2396209A1 (en) 2001-08-16
EP1257278B1 (en) 2006-02-08

Similar Documents

Publication Publication Date Title
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
NO20040097L (no) Kombinasjoner for behandling av inflammatoriske forstyrrelser
NO20021845L (no) Behandling av sovnforstyrrelser under anvendelse av desloratadin
NO20014379D0 (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20043237L (no) Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
GB0007193D0 (en) Treatment of movrmrnt disorders
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
HK1053058A1 (zh) 普拉克索用於治療成癮性疾病的用途
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
NO20041833L (no) Heterocykliske forbindelser for anvendelse i behandlingen av forstyrrelser i urinveissystemet
NO20033417L (no) Anvendelse av CD23-antagonister for behandling av neoplastiske forstyrrelser
IS6137A (is) Meðhöndlun á hugsýkistruflunum
NO20023448L (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
NO20023803L (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20032156D0 (no) Behandling av angstforstyrrelser
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
NO20005216D0 (no) Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
NO20011189L (no) Innretning for behandling av suspensjoner

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees